| Poland belongs to countries with a high rate of clarithromycin resistance (> 15%), therefore the recommended first-line treatment in Poland is quadruple therapy with bismuth (PPI, bismuth, tetracycline, nitroimidazole) or quadruple therapy without bismuth (PPI, amoxicillin, clarithromycin, nitroimidazole), given their high effectiveness and lower complexity compared to sequential or hybrid treatment. |
| Quality of evidence: moderate. Recommendation: strong. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.